27349853
|
Xiao H
|
2016
|
Metformin is a novel suppressor for transforming growth factor (TGF)-?1.
|
27350232
|
Safier LZ
|
2016
|
Use of anti-M?llerian hormone testing during ovarian reserve screening to identify women at risk of polycystic ovary syndrome.
|
27351028
|
Layegh P
|
2016
|
Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: Comparison between obese and non-obese PCOS patients.
|
27351893
|
Kudesia R
|
2016
|
Elevated Prevalence of Polycystic Ovary Syndrome and Cardiometabolic Disease in South Asian Infertility Patients.
|
27354380
|
Li Q
|
2016
|
Genetic variations in the 3'-untranslated region of SLC18A2 are associated with serum FSH concentration in polycystic ovary syndrome patients and regulate gene expression in vitro.
|
27358825
|
Pruksananonda K
|
2016
|
Epigenetic modification of long interspersed elements-1 in cumulus cells of mature and immature oocytes from patients with polycystic ovary syndrome.
|
27358832
|
Seok HH
|
2016
|
Application of serum anti-M?llerian hormone levels in selecting patients with polycystic ovary syndrome for in vitro maturation treatment.
|
27365543
|
Fischer D
|
2016
|
Avoiding OHSS: Controlled Ovarian Low-Dose Stimulation in Women with PCOS.
|
27367829
|
Gu BX
|
2016
|
Abnormal expression of TLRs may play a role in lower embryo quality of women with polycystic ovary syndrome.
|
27368923
|
Vigneri R
|
2016
|
Insulin, insulin receptors, and cancer.
|
27375552
|
Huang-Doran I
|
2016
|
Genetic Rodent Models of Obesity-Associated Ovarian Dysfunction and Subfertility: Insights into Polycystic Ovary Syndrome.
|
27375725
|
Inan C
|
2016
|
Correlation between ovarian morphology and biochemical and hormonal parameters in polycystic ovary syndrome.
|
27377844
|
Koseoglu SB
|
2016
|
Impaired olfactory function in patients with polycystic ovary syndrome.
|
27381237
|
Yousuf SD
|
2017
|
Does the Oral Contraceptive Pill Increase Plasma Intercellular Adhesion Molecule-1, Monocyte Chemoattractant Protein-1, and Tumor Necrosis Factor-? Levels in Women with Polycystic Ovary Syndrome: A Pilot Study.
|
27385973
|
Hossein-Rashidi B
|
2016
|
Recombinant FSH Compared to Clomiphene Citrate as the First-Line in Ovulation Induction in Polycystic Ovary Syndrome Using Newly Designed Pens: A Randomized Controlled Trial.
|
27386819
|
Huang S
|
2016
|
Fractalkine restores the decreased expression of StAR and progesterone in granulosa cells from patients with polycystic ovary syndrome.
|
27387253
|
Lizneva D
|
2016
|
Androgen excess: Investigations and management.
|
27392736
|
Ksouda K
|
2009
|
[Polycystic Ovary Syndrome Induced by Valproic Acid. A Case Report].
|
27401369
|
Ding T
|
2016
|
Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.
|
27402910
|
Santoro N
|
2016
|
Fertility-related quality of life from two RCT cohorts with infertility: unexplained infertility and polycystic ovary syndrome.
|
27403074
|
Kalem MN
|
2016
|
Effect of body mass index and age on in vitro fertilization in polycystic ovary syndrome.
|
27406030
|
Hwang YI
|
2016
|
Fertility of patients with polycystic ovary syndrome undergoing in vitro fertilization by age.
|
27406348
|
McCartney CR
|
2016
|
CLINICAL PRACTICE. Polycystic Ovary Syndrome.
|
27407136
|
Cao SF
|
2017
|
Effects of Exercise Intervention on Preventing Letrozole-Exposed Rats From Polycystic Ovary Syndrome.
|
27412249
|
Rowlands IJ
|
2016
|
Young women's psychological distress after a diagnosis of polycystic ovary syndrome or endometriosis.
|
27412270
|
Chung J
|
2016
|
Health-related quality-of-life questionnaire for women with polycystic ovary syndrome: a Chinese translation and validation study.
|
27412301
|
Rutkowska AZ
|
2016
|
Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
|
27412368
|
Mahalingaiah S
|
2016
|
Association of prenatal and early life exposure to tetrachloroethylene (PCE) with polycystic ovary syndrome and other reproductive disorders in the cape cod health study: A retrospective cohort study.
|
27418215
|
G?owi?ska A
|
2016
|
Determinants of emotional problems and mood disorders in women with polycystic ovary syndrome.
|
27419327
|
Williams T
|
2016
|
Diagnosis and Treatment of Polycystic Ovary Syndrome.
|
27420145
|
Fux Otta C
|
2016
|
[Polycystic ovary sindrome: impact on reproductive and material fetal health].
|
27423183
|
De Leo V
|
2016
|
Genetic, hormonal and metabolic aspects of PCOS: an update.
|
27424378
|
Mahmoud SA
|
2016
|
Adverse Long-term Metabolic and Endometrial Consequences in Women with Polycystic Ovarian Syndrome: A Report of Two Cases.
|
27424881
|
Fr?ssing S
|
2017
|
Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study.
|
27425146
|
Li S
|
2016
|
The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations.
|
27425379
|
Elci E
|
2017
|
Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries.
|
27425581
|
Ding N
|
2016
|
Luteal phase clomiphene citrate for ovulation induction in women with polycystic ovary syndrome: a systematic review and meta-analysis.
|
27426018
|
Rudnicka E
|
2016
|
Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight.
|
27426125
|
Saydam BO
|
2016
|
Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome.
|
27426126
|
Abbott DH
|
2016
|
Translational Insight Into Polycystic Ovary Syndrome (PCOS) From Female Monkeys with PCOS-like Traits.
|
27428059
|
Javed A
|
2016
|
Polycystic ovary syndrome in adolescents: a review of past year evidence.
|
27428219
|
Zhu X
|
2016
|
The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.
|
27429113
|
Draveck? I
|
2016
|
The effect of alfacalcidiol and metformin on phenotype manifestations in women with polycystic ovary syndrome - a preliminary study.
|
27432836
|
Heida KY
|
2016
|
Cardiovascular risk management after reproductive and pregnancy-related disorders: A Dutch multidisciplinary evidence-based guideline.
|
27434652
|
Gursoy Calan O
|
2016
|
Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome.
|
27437203
|
Mishra S
|
2016
|
Hypovitaminosis D and Associated Cardiometabolic Risk in Women with PCOS.
|
27445197
|
Quinn MM
|
2016
|
Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk.
|
27449565
|
Chen TS
|
2017
|
Steroidogenic enzymes of adipose tissue in modulation of trivalent chromium in a mouse model of PCOS.
|
27449893
|
Reyes-Mu?oz E
|
2016
|
Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study.
|
27450187
|
Riley JK
|
2016
|
Is there a role for diet in ameliorating the reproductive sequelae associated with chronic low-grade inflammation in polycystic ovary syndrome and obesity?
|
27450358
|
Armanini D
|
2016
|
Spironolactone in the treatment of polycystic ovary syndrome.
|
27454463
|
Jones AV
|
2016
|
Genome-wide association analysis of pain severity in dysmenorrhea identifies association at chromosome 1p13.2, near the nerve growth factor locus.
|
27456547
|
Sim SY
|
2016
|
Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?
|
27457114
|
Dhesi AS
|
2016
|
Metabolic screening in patients with polycystic ovary?syndrome is largely underutilized among obstetrician-gynecologists.
|
27459230
|
Rosenfield RL
|
2016
|
The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.
|
27459314
|
Hao M
|
2016
|
Overexpression of Lnk in the Ovaries Is Involved in Insulin Resistance in Women With Polycystic Ovary Syndrome.
|
27459445
|
Chavarro JE
|
2016
|
Contributions of the Nurses' Health Studies to Reproductive Health Research.
|
27459523
|
George JT
|
2016
|
Neurokinin B Receptor Antagonism in Women With Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Trial.
|
27461373
|
Zhang Y
|
2016
|
Molecular characterization of insulin resistance and glycolytic metabolism in the rat uterus.
|
27464726
|
Dimitriadis GK
|
2016
|
Polycystic Ovary Syndrome as a Proinflammatory State: The Role of Adipokines.
|
27465377
|
Schoenaker DA
|
2016
|
Quantifying the mediating effect of body mass index on the relation between a Mediterranean diet and development of maternal pregnancy complications: the Australian Longitudinal Study on Women's Health.
|
27468791
|
Csenteri OK
|
2017
|
The role of hyperinsulinemia as a cardiometabolic risk factor independent of obesity in polycystic ovary syndrome.
|
27470958
|
Hu WH
|
2016
|
[Expression and regulation of CD36 mRNA in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome].
|
27471004
|
Marti N
|
2017
|
Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome.
|
27472012
|
Garvey WT
|
2016
|
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines.
|
27472811
|
Ramos FK
|
2016
|
Quality of Life in Women with Polycystic Ovary Syndrome after a Program of Resistance Exercise Training.
|
27473078
|
Polak K
|
2017
|
New markers of insulin resistance in polycystic ovary syndrome.
|
27473350
|
Maas KH
|
2016
|
Androgen responses to adrenocorticotropic hormone infusion among individual women with polycystic ovary syndrome.
|
27478827
|
Yu Q
|
2016
|
Subclinical Hypothyroidism in PCOS: Impact on Presentation, Insulin Resistance, and Cardiovascular Risk.
|
27479317
|
?n B
|
2016
|
Evaluation of hs-CRP and visseral adiposity index in patients with policystic ovary syndrome by clinical and laboratory findings.
|
27483558
|
Bjelica A
|
2016
|
Comparison of the efficiency of clomiphene citrate and letrozole in combination with metformin in moderately obese clomiphene citrate-resistant polycystic ovarian syndrome patients.
|
27483702
|
P?v?leanu I
|
2016
|
TREATMENT OF METABOLIC ALTERATIONS IN POLYCYSTIC OVARY SYNDROME.
|
27484441
|
Sadeghi A
|
2017
|
Effect of omega-3 fatty acids supplementation on insulin resistance in women with polycystic ovary syndrome: Meta-analysis of randomized controlled trials.
|
27484772
|
Alebi? M?
|
2016
|
Metabolic implications of menstrual cycle length in non-hyperandrogenic women with polycystic ovarian morphology.
|
27487421
|
Rice T
|
2016
|
Polycystic Ovary Syndrome and Obsessive-Compulsive Disorder: Interactions and Psychopharmacological Considerations.
|
27487583
|
Tam?s T
|
2016
|
[Not Available].
|
27488697
|
Jacob L
|
2016
|
Caesarean section and its impact on fertility and time to a subsequent pregnancy in Germany: a database analysis in gynecological practices.
|
27488699
|
Gao J
|
2016
|
The association of DENND1A gene polymorphisms and polycystic ovary syndrome risk: a systematic review and meta-analysis.
|
27489079
|
Zhang R
|
2017
|
Oxidative stress status in Chinese women with different clinical phenotypes of polycystic ovary syndrome.
|
27490918
|
Jamilian M
|
2016
|
The Effects of Soy Isoflavones on Metabolic Status of Patients With Polycystic Ovary Syndrome.
|
27491227
|
Liang Y
|
2016
|
[Effects of Cangfu Congxian Decoction on Oxidative Stress in Polycystic Ovary Syndrome Patients].
|
27492704
|
Doggui R
|
2016
|
Immunoanalytical profile of androstenedione.
|
27493664
|
Benelli E
|
2016
|
A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women.
|
27498530
|
Bjelica A
|
2016
|
ALGORITHM OF OVULATION INDUCTION IN PATIENTS WITH POLYCISTIC OVARY SYNDROME.
|
27499286
|
Herczeg Z
|
2016
|
[Genetic and epigenetic factors of polycystic ovary syndrome].
|
27499648
|
Love JG
|
2016
|
The experiences of women with polycystic ovary syndrome on a very low-calorie diet.
|
27502954
|
Li M
|
2017
|
Serum Macroelement and Microelement Concentrations in Patients with Polycystic Ovary Syndrome: a Cross-Sectional Study.
|
27504851
|
Gawlik A
|
2016
|
Steroid Metabolomic Disease Signature of Nonsyndromic Childhood Obesity.
|
27504948
|
Rzeszowska M
|
2016
|
Anti-M?llerian hormone: a critical factor for female fertility and reproductive health.
|
27505055
|
G?bl CS
|
2016
|
To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS.
|
27505846
|
Messadi A
|
2016
|
Distribution of HLA DRB1 and DQB1 alleles and DRB1-DQB1 haplotypes among Bahraini women with polycystic ovary syndrome.
|
27506102
|
Okanovi? M
|
2016
|
VALPROATE, BIPOLAR DISORDER AND POLYCYSTIC OVARIAN SYNDROME.
|
27509101
|
Chen ZJ
|
2016
|
Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome.
|
27509107
|
Coutifaris C
|
2016
|
Freeze Only--An Evolving Standard in Clinical In Vitro Fertilization.
|
27510480
|
Luque-Ram?rez M
|
2016
|
Adrenal Hyperandrogenism and Polycystic Ovary Syndrome.
|
27510481
|
Spritzer PM
|
2016
|
Hirsutism in Polycystic Ovary Syndrome: Pathophysiology and Management.
|
27510482
|
Moghetti P
|
2016
|
Insulin Resistance and Polycystic Ovary Syndrome.
|
27510483
|
Muscogiuri G
|
2016
|
Current Insights Into Inositol Isoforms, Mediterranean and Ketogenic Diets for Polycystic Ovary Syndrome: From Bench to Bedside.
|
27510484
|
Tziomalos K
|
2016
|
Cardiovascular Risk in the Different Phenotypes of Polycystic Ovary Syndrome.
|
27510491
|
Sir-Petermann T
|
2016
|
Metabolic Features Across the Female Life Span in Women with PCOS.
|